feed
S&P 500
—
NASDAQ
—
DOW
—
RUSSELL
—
VIX
—
US10Y
—
DXY
—
EUR/USD
—
GBP/USD
—
GOLD
—
WTI
—
BTC
—
ETH
—
S&P 500
—
NASDAQ
—
DOW
—
RUSSELL
—
VIX
—
US10Y
—
DXY
—
EUR/USD
—
GBP/USD
—
GOLD
—
WTI
—
BTC
—
ETH
—
A
Arphra
Terminal
Pulse
Markets
Macro & Rates
Disclosures
Research & AI
Portfolio
Search
⌘K
Chat
Log in
Sign up
Arphra
/
Issuer
/
BIAF
BIAF
bioAffinity Technologies, Inc.
Healthcare
Medical - Diagnostics & Research
US
USD
$1.67
Live · FMP
May 29, 2026
Watchlist
AI Brief
→
Market cap
$7.57M
52w range
0.69 – 13.80
P / E
—
EPS
—
Volume
87.54K
Revenue · FY
—
Overview
Profile
Financials
Ratios
Multiples
Valuation
Factors
Quant
Themes
Trend
Thesis
Committee
Earnings
Segments
Prices
Analysts
Dividends
Corp actions
Insiders
Sentiment
ESG
Options
Disclosures
Press releases
topic:
all
earnings
guidance
dividend
buyback
mna
ipo
split
layoffs
lawsuit
regulation
rating
executive
product
macro
News sentiment · 90d
DB · scored
2026-05-08
bullish
neutral
bearish
2026-05-08
News
DB · scored
1
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
+1.00
May 08, 2026
Business Wire